Skip to main content

Advertisement

SpringerLink
Log in

U/G SNP rs111904020 in 3′UTR of STAT3 regulated by miR-214 promotes hepatocellular carcinoma development in Chinese population

  • Original Article
  • Published:
Tumor Biology

Abstract

STAT3 is an oncogene which mainly capable of regulating various biological characters by its transcriptional factor features driving thousands of genes. However, its upstream noncoding RNA-related regulations still remain unknown. In this study, we focused on the microRNA (miRNA)-associated single nucleotide polymorphisms (SNPs) in the 3′ unstranslated region (UTR) of STAT3 to investigate the further relationship of the SNPs with miRNAs among Chinese patients with hepatocellular carcinoma (HCC). We found that patients suffering from HBV infection indicated to be the susceptible population by comparing with controls. Besides, SNP rs111904020 (U/G) in STAT3, 3′UTR was involved in the occurrence of HCC by acting as tumor promoter factors. SNP rs111904020 (U/G) could be regulated by miR-214 which caused an upregulation of STAT3. Furthermore, the carriers of G genotype was related to high expression of STAT3, and larger tumor size as well as high probability of metastasis. Moreover, the SNP of U/G was associated with poor survival and high reoccurrence of HCC with a 5-year follow-up study. In conclusion, our findings have shown that the SNP rs111904020 (U/G) in STAT3 3′UTR acted as promotion factors in the HCC development through disrupting the regulatory role of miR-214 in STAT3 expression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Abbas Z, Abbas M, Abbas S, Shazi L. Hepatitis D and hepatocellular carcinoma. World J Hepatol. 2015;7(5):777–86. doi:10.4254/wjh.v7.i5.777.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Li L, Wang H. Heterogeneity of liver cancer and personalized therapy. Cancer Lett. 2015. doi:10.1016/j.canlet.2015.07.018.

    Google Scholar 

  3. Banerjee K, Resat H. Constitutive activation of STAT3 in breast cancer cells: a review. International journal of cancer Journal international du cancer. 2015. doi:10.1002/ijc.29923.

    Google Scholar 

  4. Vogel TP, Milner JD, Cooper MA. The ying and yang of STAT3 in human disease. J Clin Immunol. 2015;35(7):615–23. doi:10.1007/s10875-015-0187-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Buonaguro L, Tagliamonte M, Petrizzo A, Damiano E, Tornesello ML, Buonaguro FM. Cellular prognostic markers in hepatocellular carcinoma. Future Oncol. 2015;11(11):1591–8. doi:10.2217/fon.15.39.

    Article  CAS  PubMed  Google Scholar 

  6. Cao Q, Li YY, He WF, Zhang ZZ, Zhou Q, Liu X, et al. Interplay between microRNAs and the STAT3 signaling pathway in human cancers. Physiol Genomics. 2013;45(24):1206–14. doi:10.1152/physiolgenomics.00122.2013.

    Article  CAS  PubMed  Google Scholar 

  7. Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, Jaeger SA, et al. An HNF4alpha-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell. 2011;147(6):1233–47. doi:10.1016/j.cell.2011.10.043.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Schwabe RF, Wang TC. Targeting liver cancer: first steps toward a miRacle? Cancer Cell. 2011;20(6):698–9. doi:10.1016/j.ccr.2011.11.021.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Tomimaru Y, Eguchi H, Nagano H, Wada H, Tomokuni A, Kobayashi S, et al. MicroRNA-21 induces resistance to the anti-tumour effect of interferon-alpha/5-fluorouracil in hepatocellular carcinoma cells. Br J Cancer. 2010;103(10):1617–26. doi:10.1038/sj.bjc.6605958.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Zhang Y, Wei W, Cheng N, Wang K, Li B, Jiang X, et al. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology. 2012;56(5):1631–40. doi:10.1002/hep.25849.

    Article  CAS  PubMed  Google Scholar 

  11. Wang B, Hsu SH, Majumder S, Kutay H, Huang W, Jacob ST, et al. TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene. 2010;29(12):1787–97. doi:10.1038/onc.2009.468.

    Article  CAS  PubMed  Google Scholar 

  12. Sentinelli F, Filippi E, Fallarino M, Romeo S, Fanelli M, Buzzetti R, et al. The 3′-UTR C>T polymorphism of the oxidized LDL-receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease. Nutrition, metabolism, and cardiovascular diseases: NMCD. 2006;16(5):345–52. doi:10.1016/j.numecd.2005.06.002.

    Article  CAS  PubMed  Google Scholar 

  13. Furtek SL, Backos DS, Matheson CJ, Reigan P. Strategies and approaches of targeting STAT3 for cancer treatment. ACS Chem Biol. 2016. doi:10.1021/acschembio.5b00945.

    PubMed  Google Scholar 

  14. GoDarts, Group UDPS, Wellcome Trust Case Control C, Zhou K, Bellenguez C, Spencer CC, et al. Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nat Genet. 2011;43(2):117–20. doi:10.1038/ng.735.

    Article  Google Scholar 

  15. Bruserud O, Nepstad I, Hauge M, Hatfield KJ, Reikvam H. STAT3 as a possible therapeutic target in human malignancies: lessons from acute myeloid leukemia. Expert Rev Hematol. 2015;8(1):29–41. doi:10.1586/17474086.2015.971005.

    Article  CAS  PubMed  Google Scholar 

  16. Hamamoto R, Saloura V, Nakamura Y. Critical roles of non-histone protein lysine methylation in human tumorigenesis. Nat Rev Cancer. 2015;15(2):110–24. doi:10.1038/nrc3884.

    Article  CAS  PubMed  Google Scholar 

  17. Buchert M, Burns CJ, Ernst M. Targeting JAK kinase in solid tumors: emerging opportunities and challenges. Oncogene. 2015. doi:10.1038/onc.2015.150.

    PubMed  Google Scholar 

  18. Dutta P, Sabri N, Li J, Li WX. Role of STAT3 in lung cancer. Jak-Stat. 2014;3(4):e999503. doi:10.1080/21623996.2014.999503.

    Article  PubMed  Google Scholar 

  19. Oh EC, Vasanth S, Katsanis N. Metabolic regulation and energy homeostasis through the primary cilium. Cell Metab. 2015;21(1):21–31. doi:10.1016/j.cmet.2014.11.019.

    Article  CAS  PubMed  Google Scholar 

  20. Deguchi A. Curcumin targets in inflammation and cancer. Endocrine, metabolic & immune disorders drug targets. 2015;15(2):88–96.

    Article  CAS  Google Scholar 

  21. Rybak AP, Bristow RG, Kapoor A. Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression. Oncotarget. 2015;6(4):1900–19.

    Article  PubMed  Google Scholar 

  22. Shih TC, Tien YJ, Wen CJ, Yeh TS, Yu MC, Huang CH, et al. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. J Hepatol. 2012;57(3):584–91. doi:10.1016/j.jhep.2012.04.031.

    Article  CAS  PubMed  Google Scholar 

  23. Xia H, Ooi LL, Hui KM. MiR-214 targets beta-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma. PLoS One. 2012;7(9):e44206. doi:10.1371/journal.pone.0044206.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu Province, People’s Republic of China

    Ye Fan, Xiaofeng Qian & Chuanyong Zhang

Authors
  1. Ye Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaofeng Qian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chuanyong Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chuanyong Zhang.

Ethics declarations

All participants have provided their written informed consents to participate in this study. This study was approved by the institutional Review Board of the first affiliated hospital to Nanjing Medical University.

Conflicts of interest

None

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fan, Y., Qian, X. & Zhang, C. U/G SNP rs111904020 in 3′UTR of STAT3 regulated by miR-214 promotes hepatocellular carcinoma development in Chinese population. Tumor Biol. 37, 14629–14635 (2016). https://doi.org/10.1007/s13277-016-5352-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-016-5352-z

Keywords

Search

Navigation